| |
| |
|
| Insider
Information: |
Bancel Stephane |
| Relationship: |
Chief Executive Office... |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
5,631,371 |
|
|
Indirect Shares
|
15,615,252 |
|
|
| Direct
Value |
$244,698 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
21,246,623 |
|
|
| Total
Value |
$244,698 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Bg Medicine, Inc. |
BGMD |
Executive Chairman, Di... |
2012-11-15 |
123,167 |
2011-09-08 |
0 |
Premium* |
|
|
Syros Pharmaceuticals, Inc. |
SYRS |
Director |
2016-07-06 |
47,980 |
|
0 |
Premium* |
|
|
Moderna, Inc. |
MRNA |
Chief Executive Office... |
2024-02-16 |
5,460,224 |
2024-02-16 |
15,615,252 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
672 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 27
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MRNA |
Moderna, Inc. |
Chief Executive Officer |
• • – |
2020-04-03 |
4 |
AS |
$32.81 |
$362,419 |
I/I |
(11,046) |
662,776 |
0 |
- |
|
| MRNA |
Moderna, Inc. |
Chief Executive Officer |
• • – |
2020-04-13 |
4 |
AS |
$32.00 |
$654,784 |
I/I |
(20,462) |
9,214,897 |
0 |
- |
|
| MRNA |
Moderna, Inc. |
Chief Executive Officer |
• • – |
2020-04-13 |
4 |
AS |
$32.00 |
$100,448 |
D/D |
(3,139) |
6,699,983 |
0 |
- |
|
| MRNA |
Moderna, Inc. |
Chief Executive Officer |
• • – |
2020-04-15 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,936 |
6,697,047 |
0 |
- |
|
| MRNA |
Moderna, Inc. |
Chief Executive Officer |
• • – |
2020-04-17 |
4 |
AS |
$44.11 |
$511,936 |
I/I |
(11,046) |
640,684 |
0 |
- |
|
| MRNA |
Moderna, Inc. |
Chief Executive Officer |
• • – |
2020-04-20 |
4 |
AS |
$45.00 |
$192,105 |
D/D |
(4,269) |
6,692,778 |
0 |
- |
|
| MRNA |
Moderna, Inc. |
Chief Executive Officer |
• • – |
2020-04-20 |
4 |
AS |
$45.00 |
$576,315 |
I/I |
(12,807) |
9,210,628 |
0 |
- |
|
| MRNA |
Moderna, Inc. |
Chief Executive Officer |
• • – |
2020-04-24 |
4 |
AS |
$47.15 |
$520,819 |
I/I |
(11,046) |
629,638 |
0 |
- |
|
| MRNA |
Moderna, Inc. |
Chief Executive Officer |
• • – |
2020-05-01 |
4 |
AS |
$48.70 |
$211,796 |
D/D |
(4,349) |
6,688,429 |
0 |
- |
|
| MRNA |
Moderna, Inc. |
Chief Executive Officer |
• • – |
2020-05-01 |
4 |
AS |
$48.70 |
$1,173,329 |
I/I |
(24,093) |
9,206,279 |
0 |
- |
|
| MRNA |
Moderna, Inc. |
Chief Executive Officer |
• • – |
2020-05-08 |
4 |
AS |
$52.84 |
$624,385 |
I/I |
(11,046) |
607,546 |
0 |
- |
|
| MRNA |
Moderna, Inc. |
Chief Executive Officer |
• • – |
2020-05-11 |
4 |
AS |
$59.57 |
$201,108 |
D/D |
(3,376) |
6,685,053 |
0 |
- |
|
| MRNA |
Moderna, Inc. |
Chief Executive Officer |
• • – |
2020-05-11 |
4 |
AS |
$59.57 |
$603,265 |
I/I |
(10,127) |
7,893,252 |
0 |
- |
|
| MRNA |
Moderna, Inc. |
Chief Executive Officer |
• • – |
2020-05-12 |
4 |
A |
$0.00 |
$0 |
D/D |
55,568 |
6,740,621 |
0 |
- |
|
| MRNA |
Moderna, Inc. |
Chief Executive Officer |
• • – |
2020-05-15 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,577 |
6,739,044 |
0 |
- |
|
| MRNA |
Moderna, Inc. |
Chief Executive Officer |
• • – |
2020-05-15 |
4 |
AS |
$63.91 |
$724,200 |
I/I |
(11,046) |
596,500 |
0 |
- |
|
| MRNA |
Moderna, Inc. |
Chief Executive Officer |
• • – |
2020-05-20 |
4 |
AS |
$70.00 |
$293,020 |
D/D |
(4,186) |
6,734,858 |
0 |
- |
|
| MRNA |
Moderna, Inc. |
Chief Executive Officer |
• • – |
2020-05-20 |
4 |
AS |
$70.00 |
$879,060 |
I/I |
(12,558) |
9,198,717 |
0 |
- |
|
| MRNA |
Moderna, Inc. |
Chief Executive Officer |
• • – |
2020-05-22 |
4 |
AS |
$67.76 |
$761,250 |
I/I |
(11,046) |
585,454 |
0 |
- |
|
| MRNA |
Moderna, Inc. |
Chief Executive Officer |
• • – |
2020-05-29 |
4 |
AS |
$57.49 |
$640,887 |
I/I |
(11,046) |
574,408 |
0 |
- |
|
| MRNA |
Moderna, Inc. |
Chief Executive Officer |
• • – |
2020-06-01 |
4 |
AS |
$62.67 |
$305,704 |
D/D |
(4,878) |
6,729,980 |
0 |
- |
|
| MRNA |
Moderna, Inc. |
Chief Executive Officer |
• • – |
2020-06-01 |
4 |
AS |
$62.67 |
$917,113 |
I/I |
(14,634) |
9,193,839 |
0 |
- |
|
| MRNA |
Moderna, Inc. |
Chief Executive Officer |
• • – |
2020-06-01 |
4/A |
AS |
$62.67 |
$305,704 |
I/I |
(4,878) |
9,193,839 |
0 |
- |
|
| MRNA |
Moderna, Inc. |
Chief Executive Officer |
• • – |
2020-06-05 |
4 |
AS |
$57.42 |
$639,056 |
I/I |
(11,046) |
563,362 |
0 |
- |
|
| MRNA |
Moderna, Inc. |
Chief Executive Officer |
• • – |
2020-06-10 |
4 |
AS |
$58.80 |
$201,978 |
I/I |
(3,435) |
9,190,404 |
0 |
- |
|
672 Records found
|
|
Page 3 of 27 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
